ウイルスベクター製造の世界市場2017-2026

◆英語タイトル:Viral Vector Manufacturing - Global Market Outlook (2017-2026)
◆商品コード:SMRC904028
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2019年3月
◆ページ数:168
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,181 ⇒換算¥455,729見積依頼/購入/質問フォーム
2-5 UserUSD5,281 ⇒換算¥575,629見積依頼/購入/質問フォーム
Global Site LicenseUSD6,381 ⇒換算¥695,529見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、ウイルスベクター製造の世界市場について調査・分析し、市場概要、市場環境、ウイルスベクター製造市場規模、種類別(アデノウイルスベクター、レトロウイルスベクター、アデノ随伴ウイルスベクター、ポックスウイルス、サイトメガロウイルス)分析、疾患別(人間の疾患、獣医病) 分析、用途別(ワクチン研究、遺伝子治療)分析、エンドユーザー別(研究機関、医薬品・バイオ医薬品企業、その他)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・ エグゼクティブサマリー
・ 序文
・ ウイルスベクター製造の世界市場:市場動向分析
・ ウイルスベクター製造の世界市場:競争要因分析
・ ウイルスベクター製造の世界市場:種類別(アデノウイルスベクター、レトロウイルスベクター、アデノ随伴ウイルスベクター、ポックスウイルス、サイトメガロウイルス)
・ ウイルスベクター製造の世界市場:疾患別(人間の疾患、獣医病)
・ ウイルスベクター製造の世界市場:用途別(ワクチン研究、遺伝子治療)
・ ウイルスベクター製造の世界市場:エンドユーザー別(研究機関、医薬品・バイオ医薬品企業、その他)
・ ウイルスベクター製造の世界市場:主要地域別分析
・ ウイルスベクター製造の北米市場規模(アメリカ市場等)
・ ウイルスベクター製造のヨーロッパ市場規模
・ ウイルスベクター製造のアジア市場規模(日本市場、中国市場、インド市場等)
・ウイルスベクター製造の世界市場:主な市場開拓
・ 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Viral Vector Manufacturing Market is accounted for $227.63 million in 2017 and is expected to reach $1013 million by 2026 growing at a CAGR of 18.0% during the forecast period. The increasing prevalence of target diseases and disorders, a rising number of clinical studies and availability of funding for gene therapy development, and potential applications in novel drug delivery approaches are some of the factors propelling the market growth. However, the excessive cost of gene therapies and possible mutagenesis impede the market.

Viral Vector Manufacturing comprises the generation of these vectors, which then have to be purified in order to meet the quality attributes required for further use as gene delivery systems. Viral or non-viral vector methods are used the inefficient transfer of the therapeutic gene into the target cells. Viral vectors used in gene therapy include adenovirus, lentivirus, retrovirus, and adeno-associated viral (AAV). Non-viral vectors generally depend on delivery of plasmid DNA.

On the basis of application, Gene Therapy segment holds the significant growth during the forecast period due to the availability of effective viral vector gene therapies for rare diseases & cancers, ongoing research activities on viral vector gene therapies.

Based on geography, North America holds the major market share during the forecast period owing to rise in research activities, a large number of regenerative medicine companies, increase in the prevalence of target diseases and availability of funds.

Some of the key players profiled in the Viral Vector Manufacturing Market include Spark Therapeutics, Uniqure, Kaneka Eurogentec, Regenxbio, Finvector Vision Therapies, Novasep, Massbiologics, Merck KGaA, Cobra Biologics, Fujifilm Holdings Corporation, Lonza, Brammer Bio, Oxford Biomedica and Thermo Fisher Scientific Inc.

Types Covered:
• Adenoviral Vectors
• Retroviral Vectors
• Adeno-Associated Viral Vectors
• Pox Virus
• Cytomegalovirus
• Other Types
Diseases Covered:
• Human Disease
• Veterinary Disease

Applications Covered:
• Vaccinology
• Gene Therapy

End Users Covered:
• Research Institutes
• Pharmaceutical and Biopharmaceutical Companies
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Viral Vector Manufacturing Market, By Type
5.1 Introduction
5.2 Adenoviral Vectors
5.3 Retroviral Vectors
5.3.1 Gamma-Retroviral Vectors
5.3.2 Lentiviral Vectors
5.4 Adeno-Associated Viral Vectors
5.5 Pox Virus
5.6 Cytomegalovirus
5.7 Other Types
5.7.1 Herpes Simplex Virus Vectors

6 Global Viral Vector Manufacturing Market, By Disease
6.1 Introduction
6.2 Human Disease
6.2.1 Infectious Diseases
6.2.1.1 Influenza
6.2.1.2 Malaria
6.2.1.3 Hepatitis
6.2.2 Genetic Disorders
6.2.2.1 Human Immunodeficiency Virus (HIV)
6.2.2.2 Tuberculosis
6.2.3 Cancer
6.2.4 Other Human Diseases
6.3 Veterinary Disease
6.3.1 Avian Influenza
6.3.2 Marek’s Disease
6.3.3 Infectious Bronchitis
6.3.4 Peste des Petits Ruminants (PPR) Disease
6.3.5 Other Veterinary Diseases
6.3.5.1 Rabies
6.3.5.2 Fibromuscular Dysplasia (FMD)
6.3.5.3 Swine Influenza
6.3.5.4 Equine Influenza
6.3.5.5 Newcastle Disease

7 Global Viral Vector Manufacturing Market, By Application
7.1 Introduction
7.2 Vaccinology
7.2.1 Multivalent Vaccines
7.2.2 Multipathogen Vaccines
7.3 Gene Therapy

8 Global Viral Vector Manufacturing Market, By End User
8.1 Introduction
8.2 Research Institutes
8.3 Pharmaceutical and Biopharmaceutical Companies
8.4 Other End Users

9 Global Viral Vector Manufacturing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Spark Therapeutics
11.2 Uniqure
11.3 Kaneka Eurogentec
11.4 Regenxbio
11.5 Finvector Vision Therapies
11.6 Novasep
11.7 Massbiologics
11.8 Merck KGaA
11.9 Cobra Biologics
11.10 Fujifilm Holdings Corporation
11.11 Lonza
11.12 Brammer Bio
11.13 Oxford Biomedica
11.14 Thermo Fisher Scientific Inc.

List of Tables
1 Global Viral Vector Manufacturing Market Outlook, By Region (2016-2026) ($MN)
2 Global Viral Vector Manufacturing Market Outlook, By Type (2016-2026) ($MN)
3 Global Viral Vector Manufacturing Market Outlook, By Adenoviral Vectors (2016-2026) ($MN)
4 Global Viral Vector Manufacturing Market Outlook, By Retroviral Vectors (2016-2026) ($MN)
5 Global Viral Vector Manufacturing Market Outlook, By Gamma-Retroviral Vectors (2016-2026) ($MN)
6 Global Viral Vector Manufacturing Market Outlook, By Lentiviral Vectors (2016-2026) ($MN)
7 Global Viral Vector Manufacturing Market Outlook, By Adeno-Associated Viral Vectors (2016-2026) ($MN)
8 Global Viral Vector Manufacturing Market Outlook, By Pox Virus (2016-2026) ($MN)
9 Global Viral Vector Manufacturing Market Outlook, By Cytomegalovirus (2016-2026) ($MN)
10 Global Viral Vector Manufacturing Market Outlook, By Other Types (2016-2026) ($MN)
11 Global Viral Vector Manufacturing Market Outlook, By Herpes Simplex Virus Vectors (2016-2026) ($MN)
12 Global Viral Vector Manufacturing Market Outlook, By Disease (2016-2026) ($MN)
13 Global Viral Vector Manufacturing Market Outlook, By Human Disease (2016-2026) ($MN)
14 Global Viral Vector Manufacturing Market Outlook, By Infectious Diseases (2016-2026) ($MN)
15 Global Viral Vector Manufacturing Market Outlook, By Genetic Disorders (2016-2026) ($MN)
16 Global Viral Vector Manufacturing Market Outlook, By Cancer (2016-2026) ($MN)
17 Global Viral Vector Manufacturing Market Outlook, By Other Human Diseases (2016-2026) ($MN)
18 Global Viral Vector Manufacturing Market Outlook, By Veterinary Disease (2016-2026) ($MN)
19 Global Viral Vector Manufacturing Market Outlook, By Avian Influenza (2016-2026) ($MN)
20 Global Viral Vector Manufacturing Market Outlook, By Marek’s Disease (2016-2026) ($MN)
21 Global Viral Vector Manufacturing Market Outlook, By Infectious Bronchitis (2016-2026) ($MN)
22 Global Viral Vector Manufacturing Market Outlook, By Peste des Petits Ruminants (PPR) Disease (2016-2026) ($MN)
23 Global Viral Vector Manufacturing Market Outlook, By Other Veterinary Diseases (2016-2026) ($MN)
24 Global Viral Vector Manufacturing Market Outlook, By Application (2016-2026) ($MN)
25 Global Viral Vector Manufacturing Market Outlook, By Vaccinology (2016-2026) ($MN)
26 Global Viral Vector Manufacturing Market Outlook, By Multivalent Vaccines (2016-2026) ($MN)
27 Global Viral Vector Manufacturing Market Outlook, By Multipathogen Vaccines (2016-2026) ($MN)
28 Global Viral Vector Manufacturing Market Outlook, By Gene Therapy (2016-2026) ($MN)
29 Global Viral Vector Manufacturing Market Outlook, By End User (2016-2026) ($MN)
30 Global Viral Vector Manufacturing Market Outlook, By Research Institutes (2016-2026) ($MN)
31 Global Viral Vector Manufacturing Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2016-2026) ($MN)
32 Global Viral Vector Manufacturing Market Outlook, By Other End Users (2016-2026) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ウイルスベクター製造の世界市場2017-2026]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆